New York Codes, Rules and Regulations
Title 10 - DEPARTMENT OF HEALTH
Chapter I - State Sanitary Code
Part 2 - Communicable Diseases
Designation of Cases
Section 2.1 - Communicable diseases designated: cases, suspected cases and certain carriers to be reported to the state department of health
Current through Register Vol. 46, No. 39, September 25, 2024
(a) When used in the Public Health Law and in this Chapter, the term infectious, contagious or communicable disease, shall be held to include the following diseases and any other disease which the commissioner, in the reasonable exercise of his or her medical judgment, determines to be communicable, rapidly emergent or a significant threat to public health, provided that the disease which is added to this list solely by the commissioner's authority shall remain on the list only if confirmed by the Public Health and Health Planning Council at its next scheduled meeting:
Amebiasis
Anthrax
Arboviral infection
Babesiosis
Botulism
Brucellosis
Campylobacteriosis
Chancroid
Chlamydia trachomatis infection
Cholera
Cryptosporidiosis
Cyclosporiasis
Diphtheria
E. coli 0157:H7 infections
Ehrlichiosis
Encephalitis
Giardiasis
Glanders
Gonococcal infection
Group A Streptococcal invasive disease
Group B Streptococcal invasive disease
Hantavirus disease
Hemolytic uremic syndrome
Hemophilus influenzae (invasive disease)
Hepatitis (A; B; C)
Herpes infection in infants aged 60 days or younger (neonatal)
Hospital-associated infections (as defined in section 2.2 of this Part)
Influenza (laboratory-confirmed)
Legionellosis
Listeriosis
Lyme disease
Lymphogranuloma venereum
Malaria
Measles
Melioidosis
Meningitis
Mpox
Aseptic
Hemophilus
Meningococcal
Other (specify type) Meningococcemia Monkeypox Mumps
Pertussis (whooping cough) Plague Poliomyelitis Psittacosis Q Fever Rabies
Rocky Mountain spotted fever Rubella
Rabies
Respiratory syncytial virus (RSV) (laboratory confirmed cases of RSV or deaths caused by laboratory confirmed RSV in persons younger than 18 years)
Rocky Mountain spotted fever
Congenital rubella syndrome
Salmonellosis
Severe or novel coronavirus
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), including Pediatric Multi-system Inflammatory Syndrome, or any other complication suspected of being associated with SARS-CoV-2 infection
Severe Acute Respiratory Syndrome (SARS)
Middle East Respiratory Syndrome (MERS)
Other (specify type) Shigellosis Smallpox
Staphylococcal enterotoxin B poisoning Streptococcus pneumoniae invasive disease Syphilis, specify stage Tetanus
Typhoid
Varicella (not zoster/shingles)
Vaccinia disease: (as defined in Section 2.2 of this Part)
Toxic Shock Syndrome Trichinosis
Tuberculosis, current disease (specify site) Tularemia Typhoid
Vaccinia disease (as defined in section 2.2 of this Part) Viral hemorrhagic fever
Yersiniosis
(b) Upon receipt of a report made pursuant to section 2.10 of this Part, the city, county or district health officer shall retain a copy in his record of the reports of such communicable diseases as the State Commissioner of Health may direct, and shall retain these copies until their destruction is authorized by the State Commissioner of Health, and shall forward a copy of all reports immediately to the State Department of Health. In lieu of an individual report of each case, the city, county or district health officer may, with the written consent of the State Commissioner of Health, make such summarized reports as the commissioner may require.
(c) Any disease outbreak or unusual disease shall also be reported to the State Department of Health as provided in subdivision (b) of this section. Unusual disease is defined as a newly apparent or emerging disease or syndrome of uncertain etiology that a health care provider or the State Commissioner of Health has reason to believe could possibly be caused by a transmissible infectious agent or microbial toxin.